UT-MD Anderson Cancer Center: Dual Immunotherapy Plus Chemotherapy Benefits Specific Subset of Patients With Lung Cancer
October 10, 2024
October 10, 2024
HOUSTON, Texas, Oct. 10 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Study finds patients with advanced non-small cell lung cancer and STK11 and/or KEAP1 mutations had improved outcomes with combination treatment
* * *
Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harbor . . .
* * *
Study finds patients with advanced non-small cell lung cancer and STK11 and/or KEAP1 mutations had improved outcomes with combination treatment
* * *
Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harbor . . .